금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Tanker Rates Soar to Record as Oil Crisis Becomes Shipping Crisis
The cost of shipping crude oil soared to record highs last month as the Iran war reshuffled trade ro...
Emergency Oil Releases Risk Draining the World’s Last Supply Cushion
Earlier this week, the International Energy Agency, after consulting with G7, said it would release ...
Southeast Asia Needs More Power, But Its Weak Grid Could Be a Problem
The war in Iran has exposed a critical vulnerability in Southeast Asia’s energy markets. The region ...
Jane Street in talks to shift its $11bn in debt to investors including Pimco
Private credit deal would allow the secretive trading firm to make further investments in AI
Trump allowed to delay release of financial details in $10bn BBC defamation case
US court agrees with emergency stay requested by lawyers acting for president’s investment trust
OpenAI says Apple’s trade secrets lawsuit aims to stop employees leaving
ChatGPT maker seeks to dismiss blockbuster case as it prepares to launch its own AI device
Google DeepMind CEO Demis Hassabis steps down to become chair
The London-based AI lab will be subsumed into parent company Alphabet
Russian bombardment kills 17 in Kyiv
Ukraine warns Patriot interceptor stocks are running low as retaliatory 40-day air campaign expires
China launches global tax hunt going back decades
Fiscal pressure sparks retroactive campaign and tougher controls on future offshore capital flows
US diesel prices overtake Biden-era average in blow to Trump
Cost for fuel that powers industrial America set to remain elevated even as crude falls
Oil falls after Bessent says deal to reopen Strait of Hormuz is imminent
Brent crude drops 4% as US Treasury secretary says Washington and Tehran could reach agreement on Tuesday or Wednesday
‘Arrogance kills’: Novo chief injects risk-taking into Ozempic maker
Mike Doustdar says he is open to ‘large’ deals and group will suffer ‘failures’ as it tries to cut reliance on weight-loss drugs
AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough
Sheer mass helps when enlarged balance sheets allow for bigger bets on potential blockbuster drugs
AstraZeneca investors raise concerns over mega-merger talks
Shareholders question looming patent cliff and antitrust risks in potential $400bn tie-up with Bristol Myers Squibb
A digital iron curtain is threatening the global economy
Amid geopolitical barriers that risk slowing progress and trade, Europe can become a trusted connector